vTv Therapeutics lowers stockholder meeting quorum to 33.4%

vTv Therapeutics Inc.

Board amended Section 2.8 of Second Amended and Restated By-Laws on December 19, 2025.
Quorum requirement for any stockholder meeting reduced to 33.4% from prior threshold.
Amendment effective immediately upon Board approval.
Full text of amendment filed as Exhibit 3.1 to Form 8-K.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

vTv Therapeutics Inc.: Reduced quorum requirement for stockholder meetings to 33.4% (effective 2025-12-19).

Change: bylaw amendment
Effective: 2025-12-19

Exact text from the filing

On December 19, 2025, the Board of Directors of vTv Therapeutics Inc. (the Company) amended Section 2.8 of Article II of the Company’s Second Amended and Restated By-Laws to reduce the quorum requirement for any meeting of stockholders to 33.4%.

View on SEC.gov

261 governance changes filed in the last 30 days. Browse all governance changes →

vTv Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001641489-25-000066

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.